BOLT logo

Bolt Biotherapeutics (BOLT)

Profile

Full Name

Bolt Biotherapeutics, Inc.

Ticker Symbol

BOLT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 5, 2021

Indexes

Not included

Website

http://www.boltbio.com

Employees

52

Key Details

Price

$0.32(+0.93%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$7.69M(-2.36% YoY)

Annual EPS

-$1.65(+9.84% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.32
BOLT price is $0.32

30-Day Relative Volume

0.38
BOLT 30-day relative volume is 0.38

Price Performance

Price Most recent change

+0.93%
BOLT price was up +0.93% on Apr 11, 2025

Price YTD change

-39.44%
BOLT price is down -39.44% since January 1st

Price 1-year change

-73%
BOLT price is down -73% year-on-year

Price 3-year change

-87.09%
BOLT price is down -87.09% over the past 3 years

Price Range

Price All-time high

$43.07
BOLT price is currently -99.25% below its historical high of $43.07

Price 3-year low

$0.30
BOLT price is currently +8.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.42M
BOLT market capitalization is $12.42 million

Market cap 3-year change

-86.79%
BOLT market capitalization is down -86.79% over the past 3 years

Market cap All-time high

$1.45B
BOLT market capitalization is currently -99.14% below its historical high of $1.45 billion

Market cap sector rank

22.76%
BOLT market capitalization is higher than 22.76% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.56%
BOLT shares outstanding is up +0.56% year-on-year

Shares Outstanding 3-Year Change

+2.32%
BOLT shares outstanding is up +2.32% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.60
BOLT beta is 0.60

200-day SMA

$0.59
BOLT price is currently -44.63% below its 200-day simple moving average

50-day SMA

$0.44
BOLT price is currently -25.89% below its 50-day simple moving average

RSI

32.92
BOLT 14-day relative strength index is 32.92

Volume

0.38
BOLT 30-day relative volume is 0.38

ATR

$0.04
BOLT average true range is $0.04

10-day Historical Volatility

99.30%
BOLT 10-day historical volatility is 99.30%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$7.69M
BOLT annual revenue is $7.69 million

Revenue Analysts estimate

$2.84M
BOLT annual revenue is currently +170.47% higher than the consensus analysts' forecast

Revenue 1-year change

-2.36%
BOLT annual revenue is down -2.36% year-on-year

Revenue Sector rank

24.64%
BOLT annual revenue is higher than 24.64% of companies in Healthcare sector

EPS

EPS

-$1.65
BOLT annual earnings per share is -$1.65

EPS Analysts estimate

-$1.40
BOLT annual earnings per share is currently +17.86% higher than the consensus analysts' forecast

EPS 1-year change

+9.84%
BOLT annual earnings per share is up +9.84% year-on-year

EPS Sector rank

42.69%
BOLT annual earnings per share is higher than 42.69% of companies in Healthcare sector

Profit

Gross profit

-
BOLT annual gross profit value is unknown

Gross margin

-
BOLT annual gross profit margin value is unknown

Operating profit

-$68.24M
BOLT annual operating income is -$68.24 million

Operating margin

-887.33%
BOLT annual operating profit margin is -887.33%

Net income

-$63.12M
BOLT annual net profit is -$63.12 million

Net margin

-820.78%
BOLT annual net profit margin is -820.78%

Expenses

Total expenses

$75.93M
BOLT annual total expenses is $75.93 million

Operating expenses

$75.93M
BOLT annual total operating expenses is $75.93 million

Cost of goods sold

-
BOLT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$18.46M
BOLT annual SGA is $18.46 million

Depreciation and amortization

$1.78M
BOLT annual depreciation & amortization is $1.78 million

Interest expense

-
BOLT annual interest expense value is unknown

Income tax

-
BOLT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$68.24M
BOLT annual earnings before interest & taxes is -$68.24 million

EBITDA

-$66.45M
BOLT annual EBITDA is -$66.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$99.63M
BOLT annual total assets is $99.63 million

Non current assets

$48.82M
BOLT annual long term assets is $48.82 million

Current assets

$50.81M
BOLT annual total current assets is $50.81 million

Cash and cash equivalents

$7.21M
BOLT annual cash & cash equivalents is $7.21 million

Accounts receivable

-
BOLT annual accounts receivable value is unknown

Inventory

-
BOLT annual inventory value is unknown

Liabilities

Total liabilities

$42.43M
BOLT annual total liabilities is $42.43 million

Long term liabilities

$26.58M
BOLT annual total long term liabilities is $26.58 million

Current liabilities

$15.86M
BOLT annual total current liabilities is $15.86 million

Accounts payable

$1.51M
BOLT annual accounts payable is $1.51 million

Debt

Total debt

$25.21M
BOLT annual total debt is $25.21 million

Total debt 1-year change

+24.68%
BOLT annual total debt is up +24.68% year-on-year

Long term debt

$22.96M
BOLT annual long term debt is $22.96 million

Short term debt

$2.25M
BOLT annual short term debt is $2.25 million

Equity & Capital

Shareholders equity

$57.20M
BOLT annual stockholders equity is $57.20 million

Book value

$57.20M
BOLT annual book value is $57.20 million

Retained earnings

-$427.40M
BOLT annual retained earnings is -$427.40 million

Working capital

$34.96M
BOLT annual working capital is $34.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$61.29M
BOLT annual cash flow from operations is -$61.29 million

Cash from operations 1-year change

+11.85%
BOLT annual cash flow from operations is up +11.85% year-on-year

Cash from investing

$57.58M
BOLT annual cash flow from investing activities is $57.58 million

Cash from investing 1-year change

-18.95%
BOLT annual cash flow from investing activities is down -18.95% year-on-year

Cash from financing

$108.00K
BOLT annual cash flow from financing activities is $108.00 thousand

Cash from financing 1-year change

-57.31%
BOLT annual cash flow from financing activities is down -57.31% year-on-year

CAPEX

CAPEX

$41.00K
BOLT annual capital expenditures is $41.00 thousand

CAPEX 1-year change

-80.1%
BOLT annual capital expenditures is down -80.1% year-on-year

Free Cash Flow

Free cash flow

-$61.33M
BOLT annual free cash flow is -$61.33 million

Free cash flow 1-year change

+12.05%
BOLT annual free cash flow is up +12.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
BOLT annual gross profit margin value is unknown

Operating margin

-887.33%
BOLT annual operating profit margin is -887.33%

Net margin

-820.78%
BOLT annual net profit margin is -820.78%

ROA & ROE

ROA

-48.66%
BOLT annual return on assets is -48.66%

ROE

-74.28%
BOLT annual return on equity is -74.28%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BOLT price to earnings ratio value is unknown

PE ratio Sector rank

-
BOLT price to earnings ratio is unknown

PB Ratio

PB ratio

0.22
BOLT price to book ratio is 0.22

PB ratio Sector rank

20.39%
BOLT price to book ratio is higher than 20.39% of companies in Healthcare sector

PS Ratio

PS ratio

-
BOLT price to sales ratio value is unknown

PS ratio Sector rank

-
BOLT price to sales ratio is unknown

Enterprise value

Enterprise value

$30.43M
BOLT enterprise value is $30.43 million

Enterprise value Sector rank

36.09%
BOLT enterprise value is higher than 36.09% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.46
BOLT EV/EBITDA is -0.46

EV/EBITDA Sector rank

52.13%
BOLT EV/EBITDA is higher than 52.13% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.20
BOLT annual current ratio is 3.20

Quick ratio

-
BOLT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
BOLT annual debt to equity ratio is 0.00

Interest coverage ratio

-
BOLT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
BOLT piotroski f-score value is unknown

Altman Z-Score

-7.59
BOLT altman z-score is -7.59

Analyst ratings

Recent major analysts updates

Mar 25, 25 Stifel
Hold
Mar 25, 25 HC Wainwright & Co.
Neutral
Nov 13, 24 HC Wainwright & Co.
Neutral
Aug 15, 24 HC Wainwright & Co.
Neutral
May 15, 24 Stifel
Hold
May 15, 24 Leerink Partners
Market Perform
May 15, 24 Jones Trading
Hold
May 15, 24 HC Wainwright & Co.
Neutral
May 15, 24 Guggenheim
Neutral
Mar 22, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IMNN logo
Imunon (IMNN)
ALLR logo
Allarity Therapeutics (ALLR)
BRTX logo
BioRestorative Therapies (BRTX)
MEIP logo
MEI Pharma (MEIP)
INAB logo
IN8bio (INAB)
MetaVia (MTVA)
ONMD logo
OneMedNet (ONMD)
CRIS logo
Curis (CRIS)
Hong Kong Pharma Digital Technology Holdings Limited (HKPD)
  • What is the ticker symbol for Bolt Biotherapeutics?
  • Does Bolt Biotherapeutics pay dividends?
  • What sector is Bolt Biotherapeutics in?
  • What industry is Bolt Biotherapeutics in?
  • What country is Bolt Biotherapeutics based in?
  • When did Bolt Biotherapeutics go public?
  • Is Bolt Biotherapeutics in the S&P 500?
  • Is Bolt Biotherapeutics in the NASDAQ 100?
  • Is Bolt Biotherapeutics in the Dow Jones?
  • When was Bolt Biotherapeutics's last earnings report?
  • When does Bolt Biotherapeutics report earnings?
  • Should I buy Bolt Biotherapeutics stock now?

What is the ticker symbol for Bolt Biotherapeutics?

The ticker symbol for Bolt Biotherapeutics is NASDAQ:BOLT

Does Bolt Biotherapeutics pay dividends?

No, Bolt Biotherapeutics does not pay dividends

What sector is Bolt Biotherapeutics in?

Bolt Biotherapeutics is in the Healthcare sector

What industry is Bolt Biotherapeutics in?

Bolt Biotherapeutics is in the Biotechnology industry

What country is Bolt Biotherapeutics based in?

Bolt Biotherapeutics is headquartered in United States

When did Bolt Biotherapeutics go public?

Bolt Biotherapeutics's initial public offering (IPO) was on February 5, 2021

Is Bolt Biotherapeutics in the S&P 500?

No, Bolt Biotherapeutics is not included in the S&P 500 index

Is Bolt Biotherapeutics in the NASDAQ 100?

No, Bolt Biotherapeutics is not included in the NASDAQ 100 index

Is Bolt Biotherapeutics in the Dow Jones?

No, Bolt Biotherapeutics is not included in the Dow Jones index

When was Bolt Biotherapeutics's last earnings report?

Bolt Biotherapeutics's most recent earnings report was on Mar 24, 2025

When does Bolt Biotherapeutics report earnings?

The next expected earnings date for Bolt Biotherapeutics is May 14, 2025

Should I buy Bolt Biotherapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page